The Risky Business of Drug Development- The Final Say of National Hta Agencies on A Pharmaceutical's Benefit During The Last Stretch of An Expensive, Long-Lasting And Arduous Development Journey – As Illustrated By The Decisions Of Germany' ...

Nov 1, 2014, 00:00 AM
Section Title : Health Care Use and Policy Studies
Section Order : 647
First Page : A439
HEOR Topics :
Tags :
Regions :